Free Trial

Tandem Diabetes Care (TNDM) Competitors

Tandem Diabetes Care logo
$14.81 -0.15 (-1.00%)
As of 01:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TNDM vs. TMDX, SLNO, NVST, LIVN, INSP, WRBY, LQDA, EYE, AORT, and LMAT

Should you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Inspire Medical Systems (INSP), Warby Parker (WRBY), Liquidia Technologies (LQDA), National Vision (EYE), Artivion (AORT), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

Tandem Diabetes Care vs. Its Competitors

TransMedics Group (NASDAQ:TMDX) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

TransMedics Group presently has a consensus target price of $130.73, indicating a potential upside of 2.51%. Tandem Diabetes Care has a consensus target price of $21.19, indicating a potential upside of 43.06%. Given Tandem Diabetes Care's higher probable upside, analysts plainly believe Tandem Diabetes Care is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.62
Tandem Diabetes Care
1 Sell rating(s)
12 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.18

TransMedics Group has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500.

In the previous week, Tandem Diabetes Care had 4 more articles in the media than TransMedics Group. MarketBeat recorded 15 mentions for Tandem Diabetes Care and 11 mentions for TransMedics Group. Tandem Diabetes Care's average media sentiment score of 0.91 beat TransMedics Group's score of 0.75 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
4 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tandem Diabetes Care
6 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TransMedics Group has higher earnings, but lower revenue than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$441.54M9.85$35.46M$1.9366.08
Tandem Diabetes Care$940.20M1.06-$96.03M-$3.09-4.79

TransMedics Group has a net margin of 13.49% compared to Tandem Diabetes Care's net margin of -20.51%. TransMedics Group's return on equity of 28.02% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group13.49% 28.02% 8.64%
Tandem Diabetes Care -20.51%-65.40%-13.87%

99.7% of TransMedics Group shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

TransMedics Group beats Tandem Diabetes Care on 12 of the 16 factors compared between the two stocks.

Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNDM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNDM vs. The Competition

MetricTandem Diabetes CareMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.00B$7.57B$6.16B$10.66B
Dividend YieldN/A1.14%5.72%4.86%
P/E Ratio-4.7927.2629.5428.34
Price / Sales1.0627.77577.73128.29
Price / CashN/A22.2737.1261.42
Price / Book3.695.2612.066.50
Net Income-$96.03M$178.09M$3.32B$276.64M
7 Day Performance-3.14%-0.66%-0.48%-0.11%
1 Month Performance15.97%0.88%5.54%1.39%
1 Year Performance-53.93%2.77%65.53%32.46%

Tandem Diabetes Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNDM
Tandem Diabetes Care
4.19 of 5 stars
$14.81
-1.0%
$21.19
+43.1%
-55.4%$1.00B$940.20M-4.792,650Analyst Forecast
TMDX
TransMedics Group
2.6358 of 5 stars
$119.90
+1.9%
$127.18
+6.1%
-2.8%$4.09B$441.54M62.12210News Coverage
Upcoming Earnings
Analyst Upgrade
Gap Up
SLNO
Soleno Therapeutics
4.2856 of 5 stars
$65.45
0.0%
$115.92
+77.1%
+24.7%$3.48BN/A-15.8130
NVST
Envista
3.7028 of 5 stars
$20.14
+0.9%
$21.08
+4.7%
+6.4%$3.35B$2.51B62.9412,300News Coverage
Upcoming Earnings
LIVN
LivaNova
2.8853 of 5 stars
$54.10
+0.7%
$59.71
+10.4%
+2.9%$2.95B$1.25B-13.912,900News Coverage
Positive News
INSP
Inspire Medical Systems
4.8232 of 5 stars
$80.91
+3.7%
$148.00
+82.9%
-58.7%$2.39B$802.80M46.771,246Positive News
WRBY
Warby Parker
2.2974 of 5 stars
$21.77
+0.3%
$24.75
+13.7%
+22.6%$2.29B$821.35M-310.973,780
LQDA
Liquidia Technologies
3.6029 of 5 stars
$24.44
+8.7%
$32.38
+32.5%
+99.5%$2.10B$14M-14.3850Analyst Forecast
EYE
National Vision
2.6595 of 5 stars
$25.49
-1.2%
$24.73
-3.0%
+165.5%$2.02B$1.82B-141.6113,411Positive News
AORT
Artivion
2.731 of 5 stars
$42.53
+1.1%
$43.97
+3.4%
+63.7%$2.01B$405.04M-101.271,600
LMAT
LeMaitre Vascular
3.3772 of 5 stars
$88.01
+1.6%
$97.60
+10.9%
+3.2%$1.99B$219.86M42.72490

Related Companies and Tools


This page (NASDAQ:TNDM) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners